Manulife (Manufacturers Life Insurance)
VIR icon

Manulife (Manufacturers Life Insurance)’s Vir Biotechnology VIR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Buy
33,403
+7,248
+28% +$69K ﹤0.01% 2367
2026
Q1 		$234K Sell
26,155
-2,229
-8% -$17.8K ﹤0.01% 2402
2025
Q4 		$171K Sell
28,384
-3,273
-10% -$19.5K ﹤0.01% 2588
2025
Q3 		$181K Sell
31,657
-13,487
-30% -$69K ﹤0.01% 2616
2025
Q2 		$228K Sell
45,144
-3,028
-6% -$16.2K ﹤0.01% 2497
2025
Q1 		$312K Buy
48,172
+907
+2% +$8.06K ﹤0.01% 2325
2024
Q4 		$347K Sell
47,265
-1,026
-2% -$8.09K ﹤0.01% 2392
2024
Q3 		$362K Sell
48,291
-696
-1% -$6.04K ﹤0.01% 2398
2024
Q2 		$436K Buy
48,987
+3,605
+8% +$34.6K ﹤0.01% 2273
2024
Q1 		$460K Buy
45,382
+1,204
+3% +$12.3K ﹤0.01% 2242
2023
Q4 		$444K Sell
44,178
-962
-2% -$8.79K ﹤0.01% 2225
2023
Q3 		$423K Sell
45,140
-9,481
-17% -$135K ﹤0.01% 2210
2023
Q2 		$1.34M Buy
54,621
+23,747
+77% +$596K ﹤0.01% 1529
2023
Q1 		$718K Buy
30,874
+280
+0.9% +$7.16K ﹤0.01% 1787
2022
Q4 		$774K Buy
30,594
+564
+2% +$13.8K ﹤0.01% 1737
2022
Q3 		$579K Sell
30,030
-623
-2% -$15.8K ﹤0.01% 1882
2022
Q2 		$781K Sell
30,653
-16,570
-35% -$387K ﹤0.01% 1764
2022
Q1 		$1.22M Buy
47,223
+15,775
+50% +$468K ﹤0.01% 1665
2021
Q4 		$1.3M Sell
31,448
-315
-1% -$12.3K ﹤0.01% 1677
2021
Q3 		$1.38M Sell
31,763
-3,059
-9% -$132K ﹤0.01% 1649
2021
Q2 		$1.65M Buy
34,822
+3,626
+12% +$165K ﹤0.01% 1693
2021
Q1 		$1.6M Sell
31,196
-1,941
-6% -$105K ﹤0.01% 1641
2020
Q4 		$887K Buy
33,137
+1,450
+5% +$47.1K ﹤0.01% 1889
2020
Q3 		$1.09M Buy
31,687
+2,880
+10% +$124K ﹤0.01% 1619
2020
Q2 		$1.05M Buy
28,807
+22,196
+336% +$745K ﹤0.01% 1592
2020
Q1 		$227K Buy
+6,611
New +$178K ﹤0.01% 2247

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s VIR Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Vir Biotechnology (VIR) stake by 28% in Q2 2026, buying an estimated $69K and bringing the position to 33,403 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Manulife (Manufacturers Life Insurance) first reported a position in VIR in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.65M in Q2 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 33,403 shares of Vir Biotechnology worth $340K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 7,248 Vir Biotechnology shares in Q2 2026, an estimated $69K.
  • Vir Biotechnology made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2367 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vir Biotechnology in Q1 2020 and has held it in 26 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Vir Biotechnology position peaked at $1.65M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.